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Abstract
Intratumoural heterogeneity is known to contribute to poor therapeutic response. Variations
in oxygen tension in particular have been correlated with changes in radiation response in
vitro and at the clinical scale with overall survival. Heterogeneity at the microscopic scale in
tumour blood vessel architecture has been described, and is one source of the underlying
variations in oxygen tension. We seek to determine whether histologic scale measures of
the erratic distribution of blood vessels within a tumour can be used to predict differing radia-
tion response. Using a two-dimensional hybrid cellular automaton model of tumour growth,
we evaluate the effect of vessel distribution on cell survival outcomes of simulated radiation
therapy. Using the standard equations for the oxygen enhancement ratio for cell survival
probability under differing oxygen tensions, we calculate average radiation effect over a
range of different vessel densities and organisations. We go on to quantify the vessel distri-
bution heterogeneity and measure spatial organization using Ripley’s L function, a measure
designed to detect deviations from complete spatial randomness. We find that under differ-
ing regimes of vessel density the correlation coefficient between the measure of spatial
organization and radiation effect changes sign. This provides not only a useful way to
understand the differences seen in radiation effect for tissues based on vessel architecture,
but also an alternate explanation for the vessel normalization hypothesis.
Author Summary
In this paper we use a mathematical model, called a hybrid cellular automaton, to study
the effect of different vessel distributions on radiation therapy outcomes at the cellular
level. We show that the correlation between radiation outcome and spatial organization of
vessels changes signs between relatively low and high vessel density. Specifically, that for
relatively low vessel density, radiation efficacy is decreased when vessels are more
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homogeneously distributed, and the opposite is true, that radiation efficacy is improved,
when vessel organisation is normalised in high densities. This result suggests an alteration
to the vessel normalization hypothesis which states that normalisation of vascular beds
should improve radio- and chemo-therapeutic response, but has failed to be validated in
clinical studies. In this alteration, we show that Ripley’s L function allows discrimination
between vascular architectures in different density regimes in which the standard hypothe-
sis holds and does not hold. Further, we find that this information can be used to augment
quantitative histologic analysis of tumours to aid radiation dose personalisation.
Introduction
It is increasingly recognised that an important aspect of cancers is their heterogeneity [1]. This
heterogeneity exists between patients, between different tumours within a single patient [2],
within the differing cellular populations in a single tumour and even at the genetic scale
between cancer cells originating from the same ancestor [3]. In particular, microenvironmental
heterogeneity is becoming widely accepted as a key factor in tumour progression and response
to therapy [1]. Nutrients, growth factors, extracellular matrix and other cell types are all part of
the normal tissue that surrounds and pervades a solid tumour and has been shown to vary
widely across different tumour stages and types. This is, in part, due to the dynamic and hetero-
geneous interplay between the tumour and its microenvironment.
Radiation biologists have, for many years, understood the importance of cell biological and
microenvironmental factors on radiation response. Current radiation therapy dose planning,
however, largely neglects this information and is, instead, based on years of clinical experience
using intuition and trial and error. As such, there remains limited tailoring of dose planning to
an individual patient’s tumour. With the advent of modern quantitative histologic [4] and bio-
logical imaging methods [5], however, this paradigm is poised to change.
Research in this area over the last decade [6] has sought to understand the macroscopic spa-
tial distribution of hypoxia within tumours using non-invasive imaging. This information has
then been utilised to develop spatially heterogeneous dose plans to improve tumour control.
For example, Malinen et al. [7] inferred average oxygen concentrations from radiocontrast
concentrations measured by Dynamic Contrast Enhanced (DCE) Magnetic Resonance Imag-
ing (MRI) in a dog sarcoma. Other work to understand the effects of radiation in individual
patients has utilized MRI scans in combination with mathematical models of tumour growth.
These models have incorporated heterogeneity in cell type by considering a two compartment
spatial partial differential equation (PDE) model, separately accounting for proliferation and
motility, without consideration of oxygen effects [8] to explain different radiation responses
measured by changes in tumour size over time. More recently, cellular automaton models of
stem cell driven tumours, comprised of populations with differences in proliferative phenotype
[9] were used to compare tumour response to a range of spatially heterogeneous radiation dose
plans or to different sequencing of radio- and chemo-therapeutic strategies [10]. What is lack-
ing to date, however, is research into how tissue level microenvironmental heterogeneity can
affect radiation response, and how this could be inferred from patient data.
Heterogeneity in tumour oxygenation, in particular the occurrence of hypoxia, is a well-
known cause of radiation therapy failure [11, 12]. Work done in vitro to understand differences
in radiation effect due to oxygenation differences have been valuable, and have established an
empiric relationship called the Oxygen Enhancement Ratio (OER) [13] to understand how
radiation efficacy varies with oxygen concentration. These studies do not, however, allow us to
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understand the effects of radiation in vivo, as they do not consider the heterogeneity of oxygen-
ation at the microscopic, cellular scale.
Beyond the macroscopic changes in oxygenation, vessel and cellular density and metabo-
lism, a number of theoretical studies have suggested that the local microscopic heterogeneity in
oxygenation can vary widely in space and time in tumours [14–16] and healthy tissues [17]
alike. In addition a large body of work has sought to understand an apparent paradox of ther-
apy directed at angiogenesis, the process of new vessel creation [18]. In short, it was thought
that by blocking a cancer’s ability to create new vessels, it would be possible to starve the cancer
of nutrients and oxygen, quickly leading to its demise. While effective anti-angiogenesis drugs
have been developed, this promise never came to fruition. The leading hypothesis to explain
this failure is termed the ‘vascular normalization hypothesis’ [19], which suggests that these
drugs, which block vascular endothelial growth factor (VEGF), do not simply inhibit new vessel
production, but instead work by normalizing the vascular bed in question by pruning out inef-
fective vessels and enhancing flow in others. This hypothesis, while well supported by experi-
mental work, has not yet been able to fully explain results at the clinical scale [20]. These
studies highlight an opportunity to improve our understanding of how spatio-temporal oxygen
dynamics at the cellular scale affect tissue-level response to therapy. To this end, we develop a
computational, hybrid cellular automaton model of a tumour growing within a surrounding
normal tissue in a vascularized domain which we use to investigate whether spatial statistics
gleaned from measures of vascular organisation can be used to predict radiation efficacy. By
identifying broad relationships between in silico tissue architecture and radiation response, we
aim to progress toward a translatable method of radiation plan optimization using information
extracted from biopsies.
The remainder of this paper is structured as follows. We first elucidate our methods by
describing the underlying rules and parameters governing the cellular automaton as well as the
method of calculating oxygen transport and uptake. In the results section we describe simula-
tion results concerning healthy tissue growth in regularly arranged and then heterogeneous
vascular architectures. We then describe tumour growth and invasion in regular architectures
and follow this with observations concerning the distribution of oxygen tension in different
possible vascular organisations. We then develop a metric, based on Ripley’s L function [21],
which allows us to quantify and correlate these patterns with radiation response. We end with
a discussion of how this metric reconciles some of the difficulties with the vascular normalisa-
tion hypothesis, and suggest how the metric might be used in the clinic to personalise radiation
dose planning.
Methods
We consider the effect of a heterogeneous microenvironment through the inclusion of en face
blood vessels modelled as point sources of oxygen, and through competition of tumour cells
with an initial field of healthy cells. While the assumption that blood vessels are point sources,
and lie en facemay be a simplification of the true biological complexity, it serves as a reason-
able, and commonly used [15, 16, 22], starting point for modelling. We begin by creating a
hybrid cellular automaton (HCA) model [23] in which we describe cells by individual agents
whose states are updated over synchronous discrete time steps of fixed duration on the time-
scale of the cell cycle (automaton time steps), and which occupy sites on a two-dimensional
square lattice representing a slice of tissue. The size of the lattice spacing is chosen such that
each automaton element is approximately the size of a single cell. A second, identical lattice is
created on which we approximate the continuous concentration of a freely diffusible molecule,
representing oxygen which is updated on a finer timescale (oxygen time step—see
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supplemental information for further description of the relationship between these timescales).
While the cells and oxygen distribution are updated on separate lattices, each influences the
other. The feedback between the cells and the microenvironment is captured through a partial
differential equation (PDE) governing oxygen transport and consumption. Although the
parameter values in our model are drawn from data on a particular cancer type, the primary
brain tumour glioblastoma, most of the underlying model assumptions are likely to apply to
many other vascularised solid tumours.
Cellular automaton model of cell behaviour
Cell fate decisions in our model are determined by a number of microenvironmental and cell
state-specific thresholds and values. The order in which cells are chosen to decide their fate is
computed in a random fashion so as to avoid any order bias. To determine the position of cells
within our domain, we tessellate the continuous domain on which the PDE is defined into
squares of size Δx × Δx to arrive at a regular lattice occupied by both cells and vessels. While all
cells are assumed to be the same size and shape (a single lattice site), we model two cell types,
cancerous and healthy cells, each of which can divide to produce two identical daughters. The
probabilities and thresholds for these cell fate decisions are listed in Table 1 and Fig 1, respec-
tively, and will be discussed individually in the coming sections.
Oxygen consumption and transport. With the advent of single-cell techniques for mea-
suring oxygen consumption rates, quantitative data concerning the differential oxygen con-
sumption rates of different types of cancer cells are now available. It is widely accepted that, in
general, cancer cells are more metabolically active than healthy cells because of the Warburg
shift [24] or other metabolic abnormalities, and we thus use a modification of normal
consumption.
Table 1. Dimensional model parameters and their estimates.
Parameter Meaning Value (original units) Value (non-dimensionalised) Reference
Dc Oxygen diffusion coefﬁcient 1.0 × 10
−5 cm2 s−1 2.304 × 104 cell cycle−1 [57]
rc Maximal oxygen consumption rate 4.6 × 10
−16 mol cell−1 s−1 51.54 cell cycle−1 [53]
rp Proliferative oxygen consumption 5 × rc [53]
Δx Average cell diameter 50 μm 1 cell diameter [55]
Δt Oxygen update time step 0.25 s 1 cell cycle / 230,400 —
τ Average cell cycle time 16 h 1 cell cycle [54]
cap Hypoxic threshold 5.14 × 10
−14 mol−1 cell−1 0.1 [56]
Km Effective Michaelis-Menten constant 5.14 × 10
−15 mol−1 cell−1 0.01 [58]
cmax Arterial oxygen concentration 5.14 × 10
−13 mol−1 cell−1 1 [59]
μH Healthy tissue metabolic constant 1 1 —
μcancer/μH Cancer metabolic ratio 2 2 [60]
pd Probability of death when c < cap 0.25 cell cycle
−1 0.25 cell cycle−1 —
pH Probability of division for healthy cell 0.005 — —
pT Probability of division for tumour cell 0.01 — —
cp Quiescence threshold 1.1cap 0.11 —
KOER Effective OER constant 3.28 3.28 [13, 40, 61]
OERα,min = OERβ,min OER min constant 1 1 [13, 40, 61]
OERα,max OERα max constant 1.75 1.75 [13, 40, 61]
OERβ,max OERα max constant 3.25 3.25 [13, 40, 61]
doi:10.1371/journal.pcbi.1004712.t001
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The continuous component of our model describes the distribution and consumption of
nutrients. While it is clear that many nutrients are of biological importance, in this model we
focus on oxygen as it is central to the DNA-damaging effects of photon radiation therapy [25].
Blood vessels, which are each modeled as point sources of oxygen, occupying one lattice site,
are placed randomly throughout the lattice at the start of a given simulation, at a specified spa-
tial density Θ. While in reality, vessels can be different sizes, they tend to be normally distrib-
uted around a mean size, and a variety of metrics including number of vessels, total vessel area
and vascular fraction have been used interchangeably [26, 27]. As we are interested in the
dynamics over the time scale of radiation treatment (order days), in all simulations we neglect
vascular remodeling and angiogenesis, processes which are triggered by hypoxia and mediated
by hypoxia inducible factor-1α (HIF-1α) and VEGF, among other molecules, and have been
well studied [28, 29]. Each vessel is assumed to carry an amount of oxygen equal to that carried
in the arterial blood [30]. This oxygen is then assumed to diffuse into the surrounding tissue
and be consumed by normal and tumour cells.
Fig 1. Schematic of discrete time updating algorithm for the HCA. At each cellular automaton update, each cell in the domain undergoes a series of fate
decisions based on intrinsic cell parameters and microenvironmental cues.
doi:10.1371/journal.pcbi.1004712.g001
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The spatiotemporal evolution of the oxygen field is described by the reaction-diffusion PDE
@cðx; tÞ
@t
¼ Dcr2cðx; tÞ  fcðx; tÞ; ð1Þ
where c(x, t) is the concentration of oxygen at a given time t 0 and position x 2 (0, NΔx)2nV,
where Δx is the length of a typical cell, N is the number of lattice sites on a side of the N × N
domain and V = {x1,x2, . . ., xv} denotes the set of points occupied by blood vessels, which are v
in number. We deﬁne Dc to be the diffusion coefﬁcient of oxygen, which for simplicity we
assume to be constant, corresponding to linear, isotropic diffusion. The function fc(x, t) denotes
the cellular uptake of oxygen, whose form is given by
fcðx; tÞ ¼
(
mirðcðx; tÞÞ if a cell of type i occupies a CA lattice site at position x at time t;
0 otherwise;
ð2Þ
where i 2 {H, T} signifying healthy (H) and tumour (T) cells, respectively. Here μi is deﬁned as
the cell type-speciﬁc oxygen consumption rate constant which modulates r(c), the oxygen-
dependent consumption rate, which we assume to have Michaelis-Menten form
rðcÞ ¼ rc
c
cþ Km
 
; ð3Þ
where rc and Km denote the maximal uptake rate and effective Michaelis-Menten constant,
respectively. We supplement Eq (1) with the following initial and boundary conditions. We
begin with a spatially uniform oxygen distribution c(x, 0) = c0, a positive constant, with the
entire domain, (0, NΔx)2nV, occupied by normal cells. To simulate carcinogenesis, we replace
the cell in the central lattice site with a tumour cell. Vessels are placed throughout the domain
at a prescribed density and pattern, depending on the situation being simulated. To approxi-
mate the constant value of the oxygen concentration in the arterial blood we impose c(x, t) =
cmax at each point, x 2 V, where there is a vessel. We further impose no-ﬂux boundary condi-
tions at the edge of the domain,
n  rc ¼ 0; ð4Þ
where n is the unit normal outward vector to the domain boundary.
Proliferation. Cell proliferation is governed by a complicated set of subcellular processes,
and has been modelled in great detail [31, 32]. The cell cycle has many levels of complexity
including checkpoints, specific temporal sequences and many biophysical processes that alter
the cell shape and response to microenvironmental cues and stresses at different times in the
cycle [33]. As we are interested in a phenomenon occurring at the much larger, tissue, scale, we
will encapsulate this complexity into a simple rule set and threshold values on microenviron-
mental (oxygen) conditions and neighbourhood occupation, a common simplifying assump-
tion in models of this type [23, 34].
At each time step of the cellular automaton (see S1 Text, “Time scales and updates”) we visit
each cell and check whether the oxygen concentration c at that cell’s location exceeds a fixed
threshold value cp. If the cell is a healthy cell, then we also check if there is at least one empty
lattice site neighbouring the cell, and if a cancer cell, at least one lattice site is not filled by other
cancer cells. If either of these conditions are not met, then we consider the cell to be quiescent
at this time step. If both of these conditions are met, then we generate a uniform random num-
ber r 2 [0, 1] and check if this number is less than a fixed, model specific threshold given by pH
or pT if the cell is a ‘healthy’ or tumour cell, respectively. If it is, then we execute cell division
for that cell, placing one daughter cell in the parent cell’s location and the other daughter cell in
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a randomly chosen empty neighbouring lattice site (considering normal cells as empty spaces if
the dividing cell is a tumour cell). Under optimal conditions then, the duration of each cell’s
cycle is described by a geometric random variable.
Cell death. The main mechanisms of cancer cell death considered in this study occur due
to severe hypoxia and radiation therapy. Healthy cells can also die if they are selected for
replacement by dividing cancer cells, a situation which would normally be ascribed to a cancer
cell’s greater fitness, allowing it to out-compete healthy cells for space or nutrients locally, or
possibly secondary to an acid-mediated event [22, 24].
Cells under extreme hypoxic conditions are often found to undergo autophagy (directly
translated as ‘self-eating’), a state in which they become resistant to nutrient starvation [35],
and cells are known to die over different time scales and by different mechanisms (apoptosis
versus necrosis) depending on the magnitude and duration of the hypoxic insult. While these
differences have been shown to affect tumour growth [36], as this is not the main focus of this
model, we will simplify this scenario by assigning a rate, pd, for cell death at each cellular
automaton update, when under extreme hypoxia (i.e. c< cap where cap 2 (0, cmax] is a fixed,
model-specific positive constant).
To model the effect of radiation on heterogeneously oxygenated tissues, we begin with the
linear-quadratic model of cell survival:
SF ¼ enðadþbd2Þ; ð5Þ
where α and β are radiobiologic parameters associated phenomenologically with cell kill result-
ing from ‘single hit’ events (α) and ‘double hit’ events (β) respectively, and n represents the
number of doses of d Gy of radiation. This metric, while originally derived to ﬁt in vitro data
[37], has since been widely used to also describe the clinical efﬁcacy of radiation [38, 39].
The basic interaction driving DNA damage from radiation is mediated either by free elec-
trons or by free radicals formed by the interaction of photons with water. The DNA damage
instantiated by these mechanisms can be repaired by reduction by locally available biomole-
cules containing sulfhydryl groups [25]. This damage can be made more permanent, however,
by the presence of molecular oxygen, which binds with the DNA radical, forming a ‘non-
restorable’ organic peroxide. This damage ‘fixation’ by oxygen creates a situation in which the
damage now requires enzymatic repair, which occurs on a much longer timescale [25]. Regard-
less of the mechanism of radiation sensitisation by oxygen, the effect is well documented, and
has been modelled by replacing the parameters α and β in Eq (5) with functions of the oxygen
concentration using the oxygen enhancement ratio (OER):
aðcÞ ¼ amax
OERaðcÞ
; bðcÞ ¼ bmax
OERbðcÞ2
; ð6Þ
where αmax and βmax are the values of α and β under fully physiologically oxygenated condi-
tions and α(c), β(c) are, respectively, the values of α, β at oxygen concentration c. We deﬁne the
OER as a function of the oxygen concentration by using the empirically established relation
[13, 40]
OERðcÞ ¼ ðOERmax  OERminÞKOER
cþ KOER
þ OERmin; ð7Þ
which is solved individually for α and β (see Table 1 for parameters).
Quiescence. In response to a lack of oxygen or other nutrients or external mechanical cues
indicating overcrowding, cells enter a temporary state of quiescence during which no division
occurs [41]. We model this process through an oxygen threshold (c< cp where cp 2 [cap, cmax]
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is a fixed, model-specific positive constant) below which cellular division is not possible and by
the spatial constraint that the cell is quiescent if there are no empty neighbouring lattice sites
(using a Moore neighbourhood). In the case of a cancer cell, we require that at least one space
be empty or inhabited by a normal cell, a situation in which we assume that the cancer cell will
replace the normal cell if chosen for division. When the conditions for quiescence are no longer
present, the cell’s state of quiescence is reversed.
Normal tissue approximation. The invasion of cancer cells into healthy tissue has been
modelled extensively [34, 42–44]. While this process is not the focus of our study, we neverthe-
less must consider the healthy tissue surrounding our growing tumour, as it plays an important
role in modulating the local oxygen concentration. Previous investigations have modelled
tumour spheroid growth [45], or assumed a constant influx of oxygen from the boundary of
the tissue, but as we seek to understand how heterogeneous vascularisation affects the growth
of a tumour, we must also incorporate normal tissue effects [14]. To do this, we assume that
the entire tissue is initially comprised of normal cells, which can divide if they have sufficient
space, which consume oxygen at a rate of μH r(c) and are subject to hypoxic cell death. In addi-
tion, normal cells can die through competition with cancer cells.
Cell competition. The ability to invade into normal tissue is one of the ‘Hallmarks of Can-
cer’ [46]. Several mechanisms for this have been proposed and modelled, including degradation
of extracellular matrix by secreted proteases [42, 47] and mediated by excreted lactic acid [43,
44]. As this specific interaction is not our focus, we make the simplifying assumption that nor-
mal cells do not spatially inhibit cancer cell proliferation, and a cancer cell can freely proliferate
and place a daughter onto a lattice location where a normal cell is located, causing the normal
cell to die, either through an acid-mediated or simple fitness based competition mechanism
[48]. Normal cells, however, are spatially inhibited by cancer cells and other normal cells.
Vascular dynamics. While in healthy tissue vessels are normally patent, as tumours grow
the vasculature can experience significant spatio-temporal changes on several timescales.
There continues to be significant theoretical work to describe angiogenesis, the relatively long
timescale process of new vessel formation and pruning [23, 28, 49], as well as the shorter time-
scale biophysical processes governing vascular occlusion either through physical forces [50, 51]
or microemboli [52]. In this study, we seek only to understand the effect of heterogeneous oxy-
gen concentrations on tumour growth and progression [14]. Therefore, we consider only the
simplest scenario, in which there is no feedback from the environment to the vessels.
Coupling models in the hybrid cellular automaton
Having described each of the constituent parts of the model, we now describe how they are
coupled to form the HCA. We consider a two-dimensional lattice of size N × N, with each lat-
tice element identified by coordinates (iΔx, jΔx) where i, j 2 {1, 2, . . ., N}.
As schematised in Fig 1, at each automaton time step every cell (chosen in random order) in
the domain is subject to a series of decisions based on the current automaton state and local
oxygen concentration, c(x, t). The specific checks that each cell undergoes, regardless of its phe-
notype, are:
1. compare c(x, t) to cap and cp;
2. consume oxygen at rate μi rc, die, or remain quiescent;
3. check number of free neighbouring lattice sites;
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4. determine proliferative behaviour: if proliferative constraints are met (space and oxygen),
then consume additional oxygen for proliferation [53] and place daughter cell in randomly
chosen empty neighboring lattice site, otherwise become quiescent.
Cell-microenvironment interaction. As we endeavour to understand the effects of a het-
erogeneous oxygen distribution on healthy tissues and tumours, we must consider a number of
parameters that govern a cell’s behaviour in response to these environmental cues. Specifically,
we consider the hypoxia threshold, cap, below which cells will die, and be removed from the sys-
tem. As cell fate decisions are made on a much slower time scale than oxygen diffusion, there is
a potential for update bias which would entail cell fate decisions made long after the conditions
for these decisions were met. To reduce this, we will ascribe a probability per automaton
update, pd, to this death and removal, and update the HCA more frequently than the cell cycle
time. We further consider a baseline oxygen consumption required for cellular processes, rc,
and a threshold for cells to be proliferatively active, cp [53].
Non-dimensionalisation and parameter estimation. In order to place the model in an
appropriate spatial and temporal scale, we non-dimensionalise the system. We rescale time by
a typical cell cycle time, τ = 16 h [54], and lengths by a typical diameter Δx = 50 μm for a glioma
cell [55]. We choose to rescale the oxygen concentration to reflect the average oxygen concen-
tration in the arterial blood, estimated at about 80mmHg (5.14 × 10−13 mol−1 cell−1) [56], so
that the non-dimensional oxygen concentration at a vessel takes the value 1.
Introducing the non-dimensional variables ~x ¼ x=Dx, ~t ¼ t=t and ~c ¼ c=cmax, we deﬁne
the new non-dimensional parameters
~Dc ¼
Dct
Dx2
; ~rc ¼
trc
cmax
; ~cap ¼
cap
cmax
; ~Km ¼
Km
cmax
: ð8Þ
For notational convenience, we henceforth refer to the non-dimensional parameters only and
drop the tildes for the aforementioned parameters. See Table 1 for a full list of dimensional
parameter estimates and corresponding non-dimensional values. Details of our numerical
method for solving Eq (1) are provided in S1 Text.
Tumour control probability. The tumour control probability (TCP) is a measure that
approximates the probability of eradicating all cells within a tumour and thereby controlling
(in this case ‘curing’) it. While a number of methods, both deterministic and stochastic, have
been proposed to define such a measure [62], the most commonly used formulation assumes
that the number of surviving cells capable of proliferation after radiation follows Poisson statis-
tics and that the TCP is calculated by
TCP ¼ eN0SF; ð9Þ
where N0 is the number of cells in the tissue before radiation therapy and SF is the surviving
fraction deﬁned by Eq (5).
To compare the effect of radiation on different populations of cells in our model, we calcu-
late the total number of cells surviving a given therapeutic intervention. To this end, we con-
sider the individual survival probability of cells experiencing a given oxygen concentration. Let
Nki be the number of cells in the tissue that experience a oxygen concentration in the interval
[iΔc, (i + 1)Δc) at time tk = kΔt, for i 2 {0, . . .,M}. Here we deﬁne Δc = 0.01, andMΔc = 1,
reﬂecting the fact that the oxygen concentration is bounded by its non-dimensional value in
the arterial blood, which is 1. We assume that radiation effect is instantaneous, and represent
the time after radiation as tk+1. The number of cells experiencing an oxygen concentration in
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the interval [iΔc, (i + 1)Δc) immediately following a single radiation dose d is given by
Nkþ1i ¼ Nki eðaidþbid2Þ: ð10Þ
Thus the total number of surviving cells at time tk+1 is given by
Nkþ1 ¼
XM
i¼0
Nkþ1i : ð11Þ
To calculate the number of surviving cells in a given domain after simulated radiation, we ﬁrst
calculate the individual values of αi and βi for each interval of oxygen concentration using Eqs
(6)–(7). We can then compute the surviving fraction after a simulated single 2Gy dose of radia-
tion (d = 2Gy, n = 1) by utilising Eqs (10) and (11) and assuming a distribution of cellular-oxy-
gen given by the cellular automaton at the timestep in question.
Results
Oxygenation of healthy tissue
Regular vascular patterning preserves oxygen distribution shape but not mean. We
first model a domain seeded with only healthy cells, and regular spatial distributions of vessels
of varying density. Estimates in the literature for ‘normal’ vascular density span several orders
of magnitude and are reported using a number of different measures [26, 63, 64], so we choose
to calculate the actual physiological vascular density of this model by exploring regular vessel
spacing and healthy tissue only. In each of these cases, the pattern of the vascular distribution
will remain constant, but the spacing between the vessels, and therefore the vascular density
(number of vessels / domain size) will change.
As expected, the closer the vascular packing in the domain, the more cells can be supported
and the higher the mean oxygen tension (Fig 2). There is a critical value for vessel density
below which cells begin to die, and therefore the proportion of the domain inhabited by cells
(termed carrying capacity henceforth) drops below unity. This value is between 2.7 × 10−3 ves-
sels per lattice site and 3.1 × 10−3 vessels per lattice site for the parameters modelled (Table 1),
which is well within an order of magnitude of the vascular area to tumour area ratio reported
by Zhang et al. [65].
In addition to the carrying capacity, we investigate the distribution of cellular-oxygen con-
centration. This distribution provides a non-spatial summary statistic of an otherwise spatial
entity: we can understand how many (or what proportion) of cells within the domain exist at
certain oxygen concentrations, a measure which will become important later when we consider
the effect of radiation. In Fig 2 we note that, while the mean cellular oxygen concentration
(mean of the cell-oxygen distribution) varies considerably (from a non-dimensional value of
0.16 to 0.37), the second and third moments of the distribution vary little, with the standard
deviation staying between 0.07 − 0.08 and the skewness between 2.23 − 2.45. That is, the distri-
bution of cellular oxygen concentration maintains its variance about its mean as well as its level
of symmetry while the vascular patterning is regular.
Irregular vascular patterning results in variation in oxygen distribution shape. We
next explore how the oxygen concentration that the population of healthy tissue supported
experiences based on changes in density and patterning of vessels in irregularly vascularized
domains. While this is a situation that would not likely be seen in the healthy state, understand-
ing the behaviour of the model in this simple situation is valuable before progressing to more
complex states. To this end we simulate the resulting healthy tissue growth and maintenance in
a variety of randomly generated vascular patterns of the same density (Fig 3). We plot the final,
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Fig 2. Varying the vascular density with regular spacing affects the carrying capacity and cellular-oxygen distribution in normal tissue.We plot
healthy tissue growth and maintenance as we vary the vessel density (decreasing density from top to bottomΘ = 0.0018, 0.0024 and 0.0032). We plot
cellular distributions (left) with associated spatial oxygen concentration (middle) and non-spatial distribution of cells versus oxygen concentration (right).
These plots represent the system at dynamic equilibrium, in which cell death and birth is balanced across the tissue. The mean of the cellular-oxygen
distribution decreases with vessel density (0.26, 0.18 and 0.16, top to bottom) while the standard deviation and skewness stay approximately constant
(std = 0.09, 0.1 and 0.1, skewness = 3.18, 3.23 and 3.32). Domains are of size 100 × 100.
doi:10.1371/journal.pcbi.1004712.g002
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Fig 3. Varying vascular density affects the carrying capacity of normal tissue and the cell-oxygen concentration distribution.We show the results of
normal tissue growth and maintenance as we increase the number of randomly seeded vessels from 18 (top) to 24 (middle) to 32 (bottom) on a fixed domain
(100 × 100). Cells (left) and oxygen concentration (centre) are visualized. We plot the average distribution of healthy cells by oxygen concentration (right)
over ten runs of the simulation with different vascular distributions but constant number of vessels. Every simulation ends in a dynamic equilibrium.
doi:10.1371/journal.pcbi.1004712.g003
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stable distribution of healthy cells for a random placement of vessels for a given density (Θ =
0.0018, top; Θ = 0.0024, middle; and Θ = 0.0032, bottom) in the left and middle columns. In
the right column, we plot the average distribution of cells at specific oxygen concentrations
over ten simulations with different vascular patterns.
As expected, we see an increase in carrying capacity with increasing vascular density, similar
to the regularly vascularized scenario, with cellularity (cells / domain size) increasing from
0.557 to 0.945. In these examples of the irregularly vascularised cases, however, we find striking
differences in the distribution of cell-specific oxygen concentration (Fig 3, right). While in the
regular case (Fig 2) we find conserved cellular-oxygen distribution shapes (second and third
moments), in the irregularly vascularized case we find two changes. First, even in the highest
vessel density case there is a large peak at cap and second, the distribution becomes more and
more skewed (to the left) as the vessel density decreases (skewness ranging from 0.3820
− 0.9315).
Vascularised tumour growth and invasion
Tumour invasion speed changes with, and can be constrained by, vessel spacing in regu-
lar vascular architectures. As a tumour initially invades into healthy tissue, the vasculature
that it would encounter would be that of the healthy tissue. While we are ignoring the effects of
cell crowding, vascular deformation and angiogenesis, it is of value to understand how the
growth rate and the pattern of cancer spread would change given differing vascular spacing in
an otherwise regular vasculature. To this end, we seed a series of regularly patterned vascu-
larised domains with increasing regular vessel spacings with a single initiating cancer cell and
observe the growth. Note that, to ensure initial tumour growth, we have placed an extra vessel
at the centre of the computational domain with the initial cancer cell as in certain regular spac-
ing patterns, the centre would be an area of necrosis and the simulation would end with no can-
cer cells.
We plot the results of these simulations in Fig 4 along with the individual simulation growth
rates. We find four qualitatively different patterns/rates of growth for different vascular densities.
First, when there is high vessel density (box 1, green trace, Fig 4), the tumour undergoes rapid
growth. This approximates contact inhibited tumour growth with proliferation at the edge only.
Even in this growth regime, we begin to see necrotic areas in the bulk of the tumour (box 2, blue
trace, Fig 4). The second qualitatively different regime is when the vessel density decreases toΘ =
0.0033, and the spacing of the vasculature is such that it has lost its ability to maintain continuous
populations of cancer cells (box 3, red trace, Fig 4). In this regime, we find that the cancer’s
growth rate begins to slow, and further, that the boundary begins to become irregularly shaped as
the cancer cells have to persist in regions of hypoxia long enough to divide. Further, only when
the daughters of these cells are placed into the adjacent areas of increased oxygen, will the tumour
successfully cross the area of hypoxia, slowing the macroscopic growth. Further reduction in ves-
sel density toΘ = 0.0025 results in areas of necrosis forming in the healthy tissue and a sharp
reduction in tumour growth rate (box 4, cyan trace, Fig 4). The final scenario is defined by tissue
that is so poorly vascularized that the healthy tissue cannot maintain contiguous populations,
and the cancer cannot continue growing beyond the area of initial vessel oxygenation (box 5,
black trace, Fig 4), and would need to produce its own vessels to grow further.
Tissue carrying capacity and vessel density. We next investigate in further detail the
effect of vessel density on the carrying capacity and cellular-oxygen distribution. We consider a
domain of size N = 73 (chosen for ease of comparison for normal vessel spacing) and vary ves-
sel number from very low until we reach saturation of cells (in this case from 3 to 236 vessels).
In each simulation, we initialize the domain full of cancer cells and then allow the tissue to
Spatial Metrics of Tumour Vascular Organisation Predict Radiation Efficacy
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experience oxygen dependent birth and death until a dynamic equilibrium is reached, defined
as experiencing less than a 1% change in cell number for 50 time steps. We choose this initial
condition, instead of seeding the domain with a single cell, because, in this section, we are not
interested in growth kinetics, but instead focus on tumour bulk equilibrium characteristics.
From this point, we then record and average 100 time steps of cell and oxygen concentration
data. For each vessel number, we run 500 simulations, as detailed above, with random vessel
configuration and plot the result of each set of simulations and the associated standard devia-
tion (inset) in Fig 5.
As expected, we see a monotonic approach to cellular saturation as vessel number increases.
When we plot the standard deviation, we find that it is significantly higher in the region that is
most physiologically relevant, and that these differences can reach as high as 10% (Fig 5), mak-
ing cellularity estimates based on vascular density difficult and unreliable. Further, how the
Fig 4. Increasing spacing between vessels slows tumour growth and creates areas of necrosis. Tumours are grown in equally sized, regularly
vascularised domains with decreasing vessel density from boxes 1 to 5 (from top left:Θ = 0.0072, 0.0041, 0.0033, 0.0025, 0.0013). All plots show the
automaton state at the final time point at time t 190 days. Only the smallest vessel density (0.0013 in this figure) entirely constrains growth. Growth rate
over the first190 days is summarized in the lower right panel.
doi:10.1371/journal.pcbi.1004712.g004
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different patterns represented in these families of simulations can affect the heterogeneity of
oxygen within the domain, and the resultant cellular-oxygen distributions, is unknown.
Effect on cellular-oxygen distribution in heterogeneous domains. To begin to under-
stand how the patterning of the vasculature affects the cellular-oxygen distribution within our
simulations, we consider two cases from the sample of our simulations for two separate vessel
densities (24 and 54 vessels). We plot and compare the vascular patterns which support the
maximum and minimum cellular populations from two given vascular densities (Fig 6). We
plot the minimum cellular population represented in the left column at low (top) and high
(bottom) relative vascular densities and the maximum populations in the right column.
In both minimum population cases, there is a large peak of cells near to the hypoxic mini-
mum (cap) as well as a smaller peak around an oxygen concentration of 0.5. In the maximum
cellularity examples, however, these similarities disappear. In the low vessel density, we see that
the hypoxic population is maintained, but we have lost the central, well oxygenated fraction,
while in the high vessel density maximum population this is reversed, and we lose the hypoxic
population and the entire population is centered around normoxia. This opposite effect (losing
the hypoxic fraction in one case and increasing it in the other) would drastically change radia-
tion efficacy, suggesting that vascular organization, not just density, could play an important
role in clinical radiation therapy.
Further, we see that in each case, the maximum population is supported by more homoge-
neous vascular patterns, but that in the two cases the distributions are quite different, and
indeed the skewness reflects this.
Fig 5. Equilibrium cancer cell density versus vessel density.We plot the results of several families of simulations seeded with equal numbers of
randomly placed vessels on a fixed domain of size 73 × 73. Each data point is represented by a box which is centred on the median of 500 simulations, each
of which is the average of 100 time points after dynamic equilibrium is reached. The edges of the boxes represent the 25th and 75th percentiles, the whiskers
extend to the most extreme data points not considered outliers. Outliers are defined as any simulation outside approximately 2.7 standard deviations, and
they are plotted as red crosses. Inset we plot the standard deviations at each vessel density.
doi:10.1371/journal.pcbi.1004712.g005
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The effect of heterogeneous vascular patterns on surviving cell number
As discussed in the previous section, the organisation of vessels in our model can have a signifi-
cant effect on both the carrying capacity of a domain and also the resulting cellular-oxygen dis-
tribution of the cells inhabiting the domain. It is exactly these two values (cell number and
surviving fraction) which influence our computation of total surviving cells, a measure critical
for comparison across heterogeneous samples, and to understanding radiation efficacy at larger
scales, like TCP. How these effects are governed by vessel organisation however, we have not
yet elucidated. In this section we will investigate the effects of differing vascular patterns on
radiation efficacy.
Fig 6. Homogeneous and heterogeneous vessel patterns with same density have very different carrying capacity and cellular oxygen
distributions.We plot the equilibrium cellular-oxygen distributions and spatial oxygen distributions from the minimum and maximum cellularity examples
from two representative families (24 and 54 vessels per domain) of simulations. We see nearly 20% changes in carrying capacity in favour of the more
homogeneous distributions in both cases, and while the second and third moments of the distributions of oxygen distribution change in the same direction,
the magnitude of the changes are highly varied from the low to high density cases.
doi:10.1371/journal.pcbi.1004712.g006
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Surviving cell number after radiation varies widely with vessel pattern. To begin to
understand the variability inherent in tumour control secondary to radiation effect, we calcu-
late the number of cells surviving after a single simulated dose of 2 Gy of radiation in each sim-
ulation and plot the results as a function of vessel density (Fig 7). We previously found that as
the vessel density increases, the mean number of cells supported by the domain increases in
regular domains, and this holds in irregular domains as well (Fig B in S1 Text). All else being
equal, this should translate into an increase in the number of surviving cells after radiation.
Indeed, it does translate into a decrease in the surviving fraction after 2Gy, a standard metric
used in radiation biology (Fig C in S1 Text). However, we see that the expected relation holds
for surviving cell number as well for the low vessel density simulation families, but as the vessel
density increases above 0.01, the mean number of surviving cells counter-intuitively begins to
decrease. Further, we observe, near this transition point, that the standard deviation of surviv-
ing cells within each family of simulations peaks (Fig 7, inset). This highlights the fact that ves-
sel density, and mean oxygen, are insufficient to predict surviving cells, therefore, in order to
Fig 7. Surviving cells versus vessel density for all simulations.We plot the number of surviving cells after 2Gy of simulated radiation in each simulation
as calculated using Eq (5) modified by the OER from Eqs (6) and (7) versus the number of vessels in each case for each of the 500 simulations with constant
vessel number, but random placement, on domain size 73 × 73 at dynamic equilibrium. The edges of the boxes represent the 25th and 75th percentiles, the
whiskers extend to the most extreme data points not considered outliers. Outliers are defined as any simulation outside approximately 2.7 standard
deviations, and they are plotted as red crosses. Inset we plot the standard deviation for each family of simulations versus the vessel number.
doi:10.1371/journal.pcbi.1004712.g007
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better predict the number of surviving cells in a domain, we require a measure of vascular
organisation.
Vessel density is insufficient to predict radiation effect. We have previously shown that
vascular density is a strong predictor for the carrying capacity of the tissue in our model
(Fig 5). This is intuitive and, for regularly vascularized domains, as we expect in healthy tissue,
is sufficient to explain not only the carrying capacity, but also other measures of the cellular
distribution (e.g. the shape of the cellular-oxygen distribution). We have now shown that this
measure is not sufficient when we begin to consider heterogeneously vascularized domains, as
we know exist in cancer [66], where many possible spatial patterns can exhibit the same den-
sity. The mapping from cellular-oxygen distribution to surviving cells is straightforward in the
simulations we have presented, as the cellular-oxygen distribution can be measured directly,
and the subsequent surviving cells can be calculated using Eq (11). In routinely obtained tissue
biopsy specimens however, it is not possible to measuring oxygen concentrations at the cellular
resolution. It would therefore be of translational value to define a metric by which cellular-oxy-
gen distribution, or the subsequent radiation efficacy, could be inferred from a readily measur-
able surrogate, such as the distribution (and density) of microvessels within these samples.
Spatial metrics of vessel organisation correlate with radiation effect
The vascular normalisation hypothesis [67] suggests that radiotherapy should be more effica-
cious when applied to tissues with normalised vascular beds. To test this in our model, we
introduce a spatial metric by which to understand the overall level of spatial heterogeneity in
our simulations.
We will utilise the variance stabilized Ripley’s L function [21] to measure the deviation from
homogeneity in our vessel distributions. This measure, which is a function of distance,
describes the average number of points within a given distance of any other point. For a com-
plete description of this measure, see the supplemental information.
Spatial metrics correlate directly with carrying capacity and with radiation
response if vessel density is known
In order to allow for easy correlation, we first distill Ripley’s L function (which is a function of
distance) into a single number by taking the mean value from 0 − 19 cell diameters (from adja-
cent to a distance beyond the ability to affect one another). We calculate the mean Ripley’s L
function for all of the 500 simulations in each vessel number case and plot it against the associ-
ated carrying capacity (Fig C in S1 Text). We find a significant negative correlation for the
lower vessel densities which loses statistical significance (p-values not shown) as the domains
begin to reach confluence for all but the minority of vessel arrangements.
Fig 8 shows scatter plots of Ripley’s L function and surviving cells after radiation in 6 repre-
sentative families of the 500 simulations with increasing vessel numbers. We find that at low
vessel densities there is a strong negative correlation between Ripley’s L function and surviving
cells, but this correlation changes sign at high vessel densities, explaining the counter-intuitive
change in surviving fraction after Θ = 0.01 in Fig 7. This suggests that in situations where the
vessels are more rarefied, normalising existing vasculature could actually make radiation less
effective, in contrast to the vessel normalisation hypothesis.
Discussion
We have used an HCAmodel of vascular tumour growth in a planar domain to investigate the
dependence of cellular oxygenation and radiotherapy efficacy on vascular density and pattern-
ing. Our results indicate that simple spatial summary statistics such as Ripley’s L function,
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Fig 8. Ripley’s L function versus surviving cells after radiation.We present six scatter plots showing the relationship in each of the 500 simulations
represented in Fig 5 for a given initial vessel density between cell number surviving after 2 Gy of radiation (x-axis) and the mean of Ripley’s L function (y-axis).
We find that there is a positive correlation in the low vessel densities, and a negative correlation in the high vessel densities. All correlations are significant (p
 0.05, see Fig D in S1 Text).
doi:10.1371/journal.pcbi.1004712.g008
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which could be easily obtained from biopsy images, may predict, together with more standard
measures like vessel density, radiation therapy efficacy and the effect of vascular normalisation
on this. While our model is parameterised from glioblastoma data, we anticipate these results
to be more widely applicable to other cancer types.
Our results corroborate those of Alarcón et al. [14], who also used a HCA approach to
studying vascular tumour growth. However, our work differs in several key ways. Specifically,
the vasculature in their model lies in plane rather than en face, a choice which was made con-
sciously in our model to ease future translational validation with patient tissue samples. Fur-
ther, we have ignored several mechanisms of competition in order to focus on defining
summary measures of cellular-oxygenation status. These differences aside, Alarcón et al.
found, as we did, that heterogeneity on the scale of oxygen concentration affects cell growth,
both in overall speed of tumour growth and also in shape of resulting tissue. Further, they
reported significant heterogeneity in steady state oxygen concentration across their domains
which was dependent on vascular organisation, but this was never explored in terms of radia-
tion effect. A similar finding was reported by Al-Shammari et al. in a biophysical model of
healthy muscle tissue [17], this time in a system utilizing en face oxygen sources, as in our
work. We have observed similar changes in cellular-oxygen distributions at equilibrium, and
indeed, it is these changes that drive our findings concerning radiation effect.
We have seen that the assumption that mean vessel density, and subsequently mean oxygen-
ation, can be used as a surrogate for the number of surviving cells after radiation is insufficient.
Further, we found that the relationship between each of our vessel pattern measures and the
surviving cells after radiation exhibits a sign change in the mid vessel density range. This
change of sign in correlation means that the patterns, within a given vessel density, that take
the extreme values of each measure of vascular organization can represent opposite extremes
of radiation response. This suggests that if one were to perturb the vasculature, for example
toward a more homogeneous distribution, one could induce opposite effects on radiation
response, depending on the vessel density.
With Folkman’s discovery, in 1971, of a master tumour angiogenesis regulating factor [18],
the world thought that the suggested method of blocking this factor, by which it was promised
that we could ‘starve’ tumours of their oxygen supply, would dominate cancer research. It was
thought that a cure for cancer would occur in a short time period. However, early trials of sin-
gle agent anti-angiogenic drugs failed to produce results [20]. Later trials, with combinations of
chemotherapy and anti-angiogenic drugs, however, showed promise, but even this was discor-
dant with the leading hypothesis describing the mechanism of anti-angiogenic therapy, which
was thought to entirely starve tumours of blood supply.
It was not until 2001, when Jain suggested the ‘vascular normalisation hypothesis’ [19], that
these results could be understood under a single rubric. Jain suggested that anti-angiogenic
drugs (sometimes called vascular normalisation therapy, or VNT), instead of entirely blocking
new vessel formation, worked to normalise vasculature, pruning inefficient vessels and creating
a more regular lattice, thereby improving drug and oxygen delivery. More recent iterations of
this hypothesis also include improvement of the efficiency of existing vessels (reviewed by Jain
[67, 68]).
While this advance in our thinking has provided a way to explain the counter-intuitive
results of many trials, it still does not explain why these combinations of anti-angiogenic drugs
with chemotherapeutics (or radiation therapy) do not help all patients. Using our simple
model system, we have observed a changing correlation with spatial measures and radiation
response. This suggests that in certain cases, ‘improving’ the homogeneity of vascularisation
would hurt the radiation effect, whilst in other cases it would help: a heterogeneous response to
‘normalisation’ of vascular patterning. We show that for certain cases, vessel density held
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constant, normal vascular patterning can respond either better or worse to radiation therapy
(Fig 8).
To translate these conclusions to the clinic would first require biological validation of these
hypotheses, to include a careful study of variation in spatial vessel patterning on different spa-
tial scales within the same tumor, or possibly between spatially distinct biopsies. Further, there
are a number of model limitations to overcome. Specifically, the assumption that all vessels are
en face and all vessels are the same in terms of size and efficiency. Validation could be achieved
either through in vivo window chamber experiments, or indirectly through examination of
post-radiation surgical specimens. Model development, to include the addition of angiogenesis,
biologically derived vessel geometries, vessel size heterogeneity and collapse, could be used to
extend these predictions to more realistic situations.
If these limitations were addressed, and validation was achieved, the technology exists cur-
rently to take advantage of this new idea. Specifically, macroscopic oxygen concentrations
could be inferred from DCEMRI (or other advanced imaging) to create optimised dose plans,
as suggested by Malinen et al. [7]. This information about putative vessel density could then be
coupled with histologic measurements using automated localisation of vessels [27] and an algo-
rithm to calculate Ripley’s L. These two pieces of information could then be incorporated by
creating a temporally and a spatially optimised radiation plan whereby the appropriate radia-
tion dose would be delivered before VNT to the area that would suffer after normalisation, and
then the final radiation could be delivered after VNT to the area that would benefit from it.
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